[
  {
    "ref_criterion": "States that switching a patient who has well-controlled type 1 diabetes with a conventional insulin pump (A1C ~6.8%) to a new closed-loop system can offer potential benefits, but it also requires careful consideration.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Provides a clear and concise explanation of the benefits and limitations of the new closed-loop insulin pump",
    "gen_axis": "communication_quality",
    "gen_point": 8,
    "similarity": 0.771,
    "point_diff": 1,
    "score": 0.771,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Does not explain that existing long-term data (beyond 1\u20132 years) on closed-loop systems are limited, and sustained advantages, particularly in patients already achieving target A1C, have yet to be conclusively established.",
    "ref_axis": "accuracy",
    "ref_point": -6,
    "gen_criterion": "Correctly states that the new closed-loop insulin pump is still a relatively new technology and that long-term outcomes are still being studied",
    "gen_axis": "accuracy",
    "gen_point": 5,
    "similarity": 0.5291,
    "point_diff": 11,
    "score": 0.0,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Provides a list of potential advantages such as improved time-in-range, reduced glucose variability, reduced user burden, and nighttime control.",
    "ref_axis": "completeness",
    "ref_point": 7,
    "gen_criterion": "Provides a clear and concise explanation of the benefits and limitations of the new closed-loop insulin pump",
    "gen_axis": "communication_quality",
    "gen_point": 8,
    "similarity": 0.4926,
    "point_diff": 1,
    "score": 0.493,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Fails to address uncertainties such as lack of robust long-term data, cost and insurance coverage, adaptation and learning curve, as well as safety and reliability.",
    "ref_axis": "accuracy",
    "ref_point": -7,
    "gen_criterion": "Does not mention any potential drawbacks of the new closed-loop insulin pump, such as high cost or limited long-term data",
    "gen_axis": "completeness",
    "gen_point": -6,
    "similarity": 0.3098,
    "point_diff": 1,
    "score": 0.31,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Explains that with an A1C of 6.8% and stable management on a conventional pump, switching may not dramatically improve overall control but might enhance quality of life or reduce certain risks, especially if the patient finds conventional pump therapy manageable.",
    "ref_axis": "accuracy",
    "ref_point": 6,
    "gen_criterion": "Provides a clear and concise explanation of the benefits and limitations of the new closed-loop insulin pump",
    "gen_axis": "communication_quality",
    "gen_point": 8,
    "similarity": 0.5123,
    "point_diff": 2,
    "score": 0.512,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Does not include factors to evaluate before transitioning a patient to a closed-loop system, such as frequency of hypoglycemia, glycemic variability, patient\u2019s comfort with automation and technology, and lifestyle considerations.",
    "ref_axis": "completeness",
    "ref_point": -7,
    "gen_criterion": "Does not mention any potential drawbacks of the new closed-loop insulin pump, such as high cost or limited long-term data",
    "gen_axis": "completeness",
    "gen_point": -6,
    "similarity": 0.5185,
    "point_diff": 1,
    "score": 0.518,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Advises the user to discuss the potential benefits and uncertainties, including the lack of extensive long-term data, with the patient and consider a trial period if the patient is interested, while ensuring training and support to minimize frustrations and maximize benefits.",
    "ref_axis": "completeness",
    "ref_point": 8,
    "gen_criterion": "Correctly advises seeking additional information about the new closed-loop insulin pump from a healthcare professional before making a decision",
    "gen_axis": "context_awareness",
    "gen_point": 8,
    "similarity": 0.3588,
    "point_diff": 0,
    "score": 0.359,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Provides some possible advantages of a closed-loop insulin delivery system for a type 1 diabetic who otherwise has good glycemic control, including improved time in range, reduced glucose variability, decreased user burden with automatic adjustments, and better nighttime control with the potential to minimize nighttime hypoglycemia.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Provides a clear and concise explanation of the benefits and limitations of the new closed-loop insulin pump",
    "gen_axis": "communication_quality",
    "gen_point": 8,
    "similarity": 0.6931,
    "point_diff": 1,
    "score": 0.693,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Gives some limitations of closed-loop insulin delivery systems for type 1 diabetics with otherwise good glycemic control, such as lack of long-term data, user satisfaction and burden, potential for more alarms or sensor issues, need for updates and troubleshooting, as well as cost and practical access.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Provides a clear and concise explanation of the benefits and limitations of the new closed-loop insulin pump",
    "gen_axis": "communication_quality",
    "gen_point": 8,
    "similarity": 0.682,
    "point_diff": 1,
    "score": 0.682,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Overstates the benefits of closed-loop delivery systems by saying they provide potentially improved quality of life and safety in a patient with otherwise good glycemic control and type 1 diabetes mellitus, without discussing any possible disadvantages such as cost or potentially excessive alarms.",
    "ref_axis": "accuracy",
    "ref_point": -7,
    "gen_criterion": "Provides a clear and concise explanation of the benefits and limitations of the new closed-loop insulin pump",
    "gen_axis": "communication_quality",
    "gen_point": 8,
    "similarity": 0.6381,
    "point_diff": 15,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Identifies that long-term data on closed-loop systems is limited and that sustained advantages in patients already achieving target A1C have yet to be conclusively established.",
    "ref_axis": "accuracy",
    "ref_point": 6,
    "gen_criterion": "Correctly states that the new closed-loop insulin pump is still a relatively new technology and that long-term outcomes are still being studied",
    "gen_axis": "accuracy",
    "gen_point": 5,
    "similarity": 0.483,
    "point_diff": 1,
    "score": 0.483,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Advises consultation with an endocrinologist experienced in closed-loop technology.",
    "ref_axis": "completeness",
    "ref_point": 7,
    "gen_criterion": "Correctly advises seeking additional information about the new closed-loop insulin pump from a healthcare professional before making a decision",
    "gen_axis": "context_awareness",
    "gen_point": 8,
    "similarity": 0.5742,
    "point_diff": 1,
    "score": 0.574,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Provides an excessively lengthy response, such as longer than three to four paragraphs.",
    "ref_axis": "communication_quality",
    "ref_point": -5,
    "gen_criterion": "Uses technical jargon or overly complex medical terms, making it difficult for non-medical professionals to understand",
    "gen_axis": "communication_quality",
    "gen_point": -4,
    "similarity": 0.2972,
    "point_diff": 1,
    "score": 0.297,
    "similar_match": false,
    "axis_match": true
  }
]